biomodal Launches duet mosaic Giving Liquid Biopsy Researchers and Developers More Signal from Every Blood Draw

12 August 2026

Distinguishing 5mC and 5hmC, enabled through duet evoC and the 6-base genome, delivered an AUC of 0.95 for stage I colorectal cancer from liquid biopsy, improving the earlier detection of stage I colorectal cancer from cfDNA samples!

For Methylation Sequencing, The Cancer Is In The Details

5 March 2026

Learn how 6‑base sequencing, which separates 5mC and 5hmC detection, reveals subtle early epigenetic changes that dramatically improve stage I colorectal cancer detection compared with traditional methylation methods.

biomodal Publishes Study in Nature Communications Medicine Highlighting Breakthrough in Earlier Colorectal Cancer Detection

20 January 2026

Products

Discover

duet product family

duet 6-base mosaic

duet +modC mosaic

duet evoC

duet +modC

Custom solutions

modality XPLR

Applications and research areas

Explore

Cancer research

Neurodegenerative disease

Ageing

Precision medicine

Liquid biopsy

Resources

Learn

Resource library

Customer stories

Customer documentation portal

About biomodal

Connect

About

Leadership

News

Events

Certified Service Providers

Careers

Contact

CEGX presents sequencing technology at Biology of Genomes 2022

Keep reading

biomodal Launches duet mosaic Giving Liquid Biopsy Researchers and Developers More Signal from Every Blood Draw

For Methylation Sequencing, The Cancer Is In The Details

biomodal Publishes Study in Nature Communications Medicine Highlighting Breakthrough in Earlier Colorectal Cancer Detection

Discover

Explore

Connect

Legal

Products

Discover

Applications and research areas

Explore

Resources

Learn

About biomodal

Connect

CEGX presents sequencing technology at Biology of Genomes 2022

Keep reading

Discover

Explore

Connect

Legal

What are you looking for?